Global Human Plasma Derivative Production, Demand and Key Producers, 2022-2028
Plasma derivatives are products manufactured from human plasma by chromatographic and other fractionation techniques.
This report studies the global Human Plasma Derivative production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Plasma Derivative, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Plasma Derivative that contribute to its increasing demand across many markets.
The global Human Plasma Derivative market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Human Plasma Derivative total production and demand, 2017-2028, (Tons)
Global Human Plasma Derivative total production value, 2017-2028, (USD Million)
Global Human Plasma Derivative production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Tons)
Global Human Plasma Derivative consumption by region & country, CAGR, 2017-2028 & (Tons)
U.S. VS China: Human Plasma Derivative domestic production, consumption, key domestic manufacturers and share
Global Human Plasma Derivative production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Tons)
Global Human Plasma Derivative production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Tons)
Global Human Plasma Derivative production by Application production, value, CAGR, 2017-2028, (USD Million) & (Tons)
This reports profiles key players in the global Human Plasma Derivative market based on the following parameters – headquarters, production locations, products portfolio, Human Plasma Derivative revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Plasma Derivative market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Human Plasma Derivative Market, By Region:
1. How big is the global Human Plasma Derivative market?
2. What is the demand of the global Human Plasma Derivative market?
3. What is the year over year growth of the global Human Plasma Derivative market?
4. What is the production and production value of the global Human Plasma Derivative market?
5. Who are the key producers in the global Human Plasma Derivative market?
6. What are the growth factors driving the market demand?
This report studies the global Human Plasma Derivative production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Plasma Derivative, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Plasma Derivative that contribute to its increasing demand across many markets.
The global Human Plasma Derivative market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Human Plasma Derivative total production and demand, 2017-2028, (Tons)
Global Human Plasma Derivative total production value, 2017-2028, (USD Million)
Global Human Plasma Derivative production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Tons)
Global Human Plasma Derivative consumption by region & country, CAGR, 2017-2028 & (Tons)
U.S. VS China: Human Plasma Derivative domestic production, consumption, key domestic manufacturers and share
Global Human Plasma Derivative production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Tons)
Global Human Plasma Derivative production by Type, production, value, CAGR, 2017-2028, (USD Million) & (Tons)
Global Human Plasma Derivative production by Application production, value, CAGR, 2017-2028, (USD Million) & (Tons)
This reports profiles key players in the global Human Plasma Derivative market based on the following parameters – headquarters, production locations, products portfolio, Human Plasma Derivative revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Plasma Derivative market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Human Plasma Derivative Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Albumin
- Blood coagulation Factors
- Immuno Globulins
- Haptoglobin
- C1-Inactivator
- Hospitals
- Clinics
- Biology Laboratory
- Others
- CSL Behring
- Baxalta (Takeda)
- Grifols
- Octapharma
- SK Plasma
- Fusion Health Care
- Baxter International
- Beijing Tiantan Biological Products Corporation
- Hualan Biological
- Shanghai RAAS Blood Products
- Shandong Taibang Biological Products
- China Resources Boya Bio-pharmaceutical Group
1. How big is the global Human Plasma Derivative market?
2. What is the demand of the global Human Plasma Derivative market?
3. What is the year over year growth of the global Human Plasma Derivative market?
4. What is the production and production value of the global Human Plasma Derivative market?
5. Who are the key producers in the global Human Plasma Derivative market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Human Plasma Derivative Introduction
1.2 World Human Plasma Derivative Supply & Forecast
1.2.1 World Human Plasma Derivative Production Value (2017 & 2021 & 2028)
1.2.2 World Human Plasma Derivative Production (2017-2028)
1.2.3 World Human Plasma Derivative Pricing Trends (2017-2028)
1.3 World Human Plasma Derivative Production by Region
1.3.1 World Human Plasma Derivative Production Value by Region (2017-2028)
1.3.2 World Human Plasma Derivative Production by Region (2017-2028)
1.3.3 World Human Plasma Derivative Average Price by Region (2017-2028)
1.3.4 North America Human Plasma Derivative Production (2017-2028)
1.3.5 Europe Human Plasma Derivative Production (2017-2028)
1.3.6 China Human Plasma Derivative Production (2017-2028)
1.3.7 Japan Human Plasma Derivative Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Plasma Derivative Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Plasma Derivative Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Plasma Derivative Demand (2017-2028)
2.2 World Human Plasma Derivative Consumption by Region
2.2.1 World Human Plasma Derivative Consumption by Region (2017-2022)
2.2.2 World Human Plasma Derivative Consumption Forecast by Region (2023-2028)
2.3 United States Human Plasma Derivative Consumption (2017-2028)
2.4 China Human Plasma Derivative Consumption (2017-2028)
2.5 Europe Human Plasma Derivative Consumption (2017-2028)
2.6 Japan Human Plasma Derivative Consumption (2017-2028)
2.7 South Korea Human Plasma Derivative Consumption (2017-2028)
2.8 ASEAN Human Plasma Derivative Consumption (2017-2028)
2.9 India Human Plasma Derivative Consumption (2017-2028)
3 WORLD HUMAN PLASMA DERIVATIVE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Plasma Derivative Production Value by Manufacturer (2017-2022)
3.2 World Human Plasma Derivative Production by Manufacturer (2017-2022)
3.3 World Human Plasma Derivative Average Price by Manufacturer (2017-2022)
3.4 Human Plasma Derivative Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Plasma Derivative Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Plasma Derivative in 2021
3.5.3 Global Concentration Ratios (CR8) for Human Plasma Derivative in 2021
3.6 Human Plasma Derivative Market: Overall Company Footprint Analysis
3.6.1 Human Plasma Derivative Market: Region Footprint
3.6.2 Human Plasma Derivative Market: Company Product Type Footprint
3.6.3 Human Plasma Derivative Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Plasma Derivative Production Value Comparison
4.1.1 United States VS China: Human Plasma Derivative Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Human Plasma Derivative Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Human Plasma Derivative Production Comparison
4.2.1 United States VS China: Human Plasma Derivative Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Human Plasma Derivative Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Human Plasma Derivative Consumption Comparison
4.3.1 United States VS China: Human Plasma Derivative Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Human Plasma Derivative Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Human Plasma Derivative Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Human Plasma Derivative in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022)
4.5 China Human Plasma Derivative Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Human Plasma Derivative in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Human Plasma Derivative Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Human Plasma Derivative in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Plasma Derivative Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Albumin
5.2.2 Blood coagulation Factors
5.2.3 Immuno Globulins
5.2.4 Haptoglobin
5.2.5 C1-Inactivator
5.3 Market Segment by Type
5.3.1 World Human Plasma Derivative Production by Type (2017-2028)
5.3.2 World Human Plasma Derivative Production Value by Type (2017-2028)
5.3.3 World Human Plasma Derivative Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Plasma Derivative Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Biology Laboratory
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Human Plasma Derivative Production by Application (2017-2028)
6.3.2 World Human Plasma Derivative Production Value by Application (2017-2028)
6.3.3 World Human Plasma Derivative Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 CSL Behring
7.1.1 CSL Behring Details
7.1.2 CSL Behring Major Business
7.1.3 CSL Behring Human Plasma Derivative Product and Services
7.1.4 CSL Behring Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 CSL Behring Recent Developments/Updates
7.1.6 CSL Behring Competitive Strengths & Weaknesses
7.2 Baxalta (Takeda)
7.2.1 Baxalta (Takeda) Details
7.2.2 Baxalta (Takeda) Major Business
7.2.3 Baxalta (Takeda) Human Plasma Derivative Product and Services
7.2.4 Baxalta (Takeda) Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Baxalta (Takeda) Recent Developments/Updates
7.2.6 Baxalta (Takeda) Competitive Strengths & Weaknesses
7.3 Grifols
7.3.1 Grifols Details
7.3.2 Grifols Major Business
7.3.3 Grifols Human Plasma Derivative Product and Services
7.3.4 Grifols Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Grifols Recent Developments/Updates
7.3.6 Grifols Competitive Strengths & Weaknesses
7.4 Octapharma
7.4.1 Octapharma Details
7.4.2 Octapharma Major Business
7.4.3 Octapharma Human Plasma Derivative Product and Services
7.4.4 Octapharma Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Octapharma Recent Developments/Updates
7.4.6 Octapharma Competitive Strengths & Weaknesses
7.5 SK Plasma
7.5.1 SK Plasma Details
7.5.2 SK Plasma Major Business
7.5.3 SK Plasma Human Plasma Derivative Product and Services
7.5.4 SK Plasma Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 SK Plasma Recent Developments/Updates
7.5.6 SK Plasma Competitive Strengths & Weaknesses
7.6 Fusion Health Care
7.6.1 Fusion Health Care Details
7.6.2 Fusion Health Care Major Business
7.6.3 Fusion Health Care Human Plasma Derivative Product and Services
7.6.4 Fusion Health Care Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Fusion Health Care Recent Developments/Updates
7.6.6 Fusion Health Care Competitive Strengths & Weaknesses
7.7 Baxter International
7.7.1 Baxter International Details
7.7.2 Baxter International Major Business
7.7.3 Baxter International Human Plasma Derivative Product and Services
7.7.4 Baxter International Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Baxter International Recent Developments/Updates
7.7.6 Baxter International Competitive Strengths & Weaknesses
7.8 Beijing Tiantan Biological Products Corporation
7.8.1 Beijing Tiantan Biological Products Corporation Details
7.8.2 Beijing Tiantan Biological Products Corporation Major Business
7.8.3 Beijing Tiantan Biological Products Corporation Human Plasma Derivative Product and Services
7.8.4 Beijing Tiantan Biological Products Corporation Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Beijing Tiantan Biological Products Corporation Recent Developments/Updates
7.8.6 Beijing Tiantan Biological Products Corporation Competitive Strengths & Weaknesses
7.9 Hualan Biological
7.9.1 Hualan Biological Details
7.9.2 Hualan Biological Major Business
7.9.3 Hualan Biological Human Plasma Derivative Product and Services
7.9.4 Hualan Biological Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Hualan Biological Recent Developments/Updates
7.9.6 Hualan Biological Competitive Strengths & Weaknesses
7.10 Shanghai RAAS Blood Products
7.10.1 Shanghai RAAS Blood Products Details
7.10.2 Shanghai RAAS Blood Products Major Business
7.10.3 Shanghai RAAS Blood Products Human Plasma Derivative Product and Services
7.10.4 Shanghai RAAS Blood Products Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Shanghai RAAS Blood Products Recent Developments/Updates
7.10.6 Shanghai RAAS Blood Products Competitive Strengths & Weaknesses
7.11 Shandong Taibang Biological Products
7.11.1 Shandong Taibang Biological Products Details
7.11.2 Shandong Taibang Biological Products Major Business
7.11.3 Shandong Taibang Biological Products Human Plasma Derivative Product and Services
7.11.4 Shandong Taibang Biological Products Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Shandong Taibang Biological Products Recent Developments/Updates
7.11.6 Shandong Taibang Biological Products Competitive Strengths & Weaknesses
7.12 China Resources Boya Bio-pharmaceutical Group
7.12.1 China Resources Boya Bio-pharmaceutical Group Details
7.12.2 China Resources Boya Bio-pharmaceutical Group Major Business
7.12.3 China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Product and Services
7.12.4 China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 China Resources Boya Bio-pharmaceutical Group Recent Developments/Updates
7.12.6 China Resources Boya Bio-pharmaceutical Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Human Plasma Derivative and Key Manufacturers
8.2 Human Plasma Derivative Manufacturing Costs
8.3 Human Plasma Derivative Production Process
8.4 Human Plasma Derivative Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Human Plasma Derivative Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Human Plasma Derivative Typical Distributors
9.3 Human Plasma Derivative Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Human Plasma Derivative Introduction
1.2 World Human Plasma Derivative Supply & Forecast
1.2.1 World Human Plasma Derivative Production Value (2017 & 2021 & 2028)
1.2.2 World Human Plasma Derivative Production (2017-2028)
1.2.3 World Human Plasma Derivative Pricing Trends (2017-2028)
1.3 World Human Plasma Derivative Production by Region
1.3.1 World Human Plasma Derivative Production Value by Region (2017-2028)
1.3.2 World Human Plasma Derivative Production by Region (2017-2028)
1.3.3 World Human Plasma Derivative Average Price by Region (2017-2028)
1.3.4 North America Human Plasma Derivative Production (2017-2028)
1.3.5 Europe Human Plasma Derivative Production (2017-2028)
1.3.6 China Human Plasma Derivative Production (2017-2028)
1.3.7 Japan Human Plasma Derivative Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Plasma Derivative Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Plasma Derivative Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Plasma Derivative Demand (2017-2028)
2.2 World Human Plasma Derivative Consumption by Region
2.2.1 World Human Plasma Derivative Consumption by Region (2017-2022)
2.2.2 World Human Plasma Derivative Consumption Forecast by Region (2023-2028)
2.3 United States Human Plasma Derivative Consumption (2017-2028)
2.4 China Human Plasma Derivative Consumption (2017-2028)
2.5 Europe Human Plasma Derivative Consumption (2017-2028)
2.6 Japan Human Plasma Derivative Consumption (2017-2028)
2.7 South Korea Human Plasma Derivative Consumption (2017-2028)
2.8 ASEAN Human Plasma Derivative Consumption (2017-2028)
2.9 India Human Plasma Derivative Consumption (2017-2028)
3 WORLD HUMAN PLASMA DERIVATIVE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Plasma Derivative Production Value by Manufacturer (2017-2022)
3.2 World Human Plasma Derivative Production by Manufacturer (2017-2022)
3.3 World Human Plasma Derivative Average Price by Manufacturer (2017-2022)
3.4 Human Plasma Derivative Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Plasma Derivative Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Plasma Derivative in 2021
3.5.3 Global Concentration Ratios (CR8) for Human Plasma Derivative in 2021
3.6 Human Plasma Derivative Market: Overall Company Footprint Analysis
3.6.1 Human Plasma Derivative Market: Region Footprint
3.6.2 Human Plasma Derivative Market: Company Product Type Footprint
3.6.3 Human Plasma Derivative Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Plasma Derivative Production Value Comparison
4.1.1 United States VS China: Human Plasma Derivative Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Human Plasma Derivative Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Human Plasma Derivative Production Comparison
4.2.1 United States VS China: Human Plasma Derivative Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Human Plasma Derivative Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Human Plasma Derivative Consumption Comparison
4.3.1 United States VS China: Human Plasma Derivative Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Human Plasma Derivative Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Human Plasma Derivative Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Human Plasma Derivative in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022)
4.5 China Human Plasma Derivative Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Human Plasma Derivative in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Human Plasma Derivative Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Human Plasma Derivative in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Plasma Derivative Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Albumin
5.2.2 Blood coagulation Factors
5.2.3 Immuno Globulins
5.2.4 Haptoglobin
5.2.5 C1-Inactivator
5.3 Market Segment by Type
5.3.1 World Human Plasma Derivative Production by Type (2017-2028)
5.3.2 World Human Plasma Derivative Production Value by Type (2017-2028)
5.3.3 World Human Plasma Derivative Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Plasma Derivative Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Biology Laboratory
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Human Plasma Derivative Production by Application (2017-2028)
6.3.2 World Human Plasma Derivative Production Value by Application (2017-2028)
6.3.3 World Human Plasma Derivative Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 CSL Behring
7.1.1 CSL Behring Details
7.1.2 CSL Behring Major Business
7.1.3 CSL Behring Human Plasma Derivative Product and Services
7.1.4 CSL Behring Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 CSL Behring Recent Developments/Updates
7.1.6 CSL Behring Competitive Strengths & Weaknesses
7.2 Baxalta (Takeda)
7.2.1 Baxalta (Takeda) Details
7.2.2 Baxalta (Takeda) Major Business
7.2.3 Baxalta (Takeda) Human Plasma Derivative Product and Services
7.2.4 Baxalta (Takeda) Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Baxalta (Takeda) Recent Developments/Updates
7.2.6 Baxalta (Takeda) Competitive Strengths & Weaknesses
7.3 Grifols
7.3.1 Grifols Details
7.3.2 Grifols Major Business
7.3.3 Grifols Human Plasma Derivative Product and Services
7.3.4 Grifols Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Grifols Recent Developments/Updates
7.3.6 Grifols Competitive Strengths & Weaknesses
7.4 Octapharma
7.4.1 Octapharma Details
7.4.2 Octapharma Major Business
7.4.3 Octapharma Human Plasma Derivative Product and Services
7.4.4 Octapharma Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Octapharma Recent Developments/Updates
7.4.6 Octapharma Competitive Strengths & Weaknesses
7.5 SK Plasma
7.5.1 SK Plasma Details
7.5.2 SK Plasma Major Business
7.5.3 SK Plasma Human Plasma Derivative Product and Services
7.5.4 SK Plasma Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 SK Plasma Recent Developments/Updates
7.5.6 SK Plasma Competitive Strengths & Weaknesses
7.6 Fusion Health Care
7.6.1 Fusion Health Care Details
7.6.2 Fusion Health Care Major Business
7.6.3 Fusion Health Care Human Plasma Derivative Product and Services
7.6.4 Fusion Health Care Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Fusion Health Care Recent Developments/Updates
7.6.6 Fusion Health Care Competitive Strengths & Weaknesses
7.7 Baxter International
7.7.1 Baxter International Details
7.7.2 Baxter International Major Business
7.7.3 Baxter International Human Plasma Derivative Product and Services
7.7.4 Baxter International Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Baxter International Recent Developments/Updates
7.7.6 Baxter International Competitive Strengths & Weaknesses
7.8 Beijing Tiantan Biological Products Corporation
7.8.1 Beijing Tiantan Biological Products Corporation Details
7.8.2 Beijing Tiantan Biological Products Corporation Major Business
7.8.3 Beijing Tiantan Biological Products Corporation Human Plasma Derivative Product and Services
7.8.4 Beijing Tiantan Biological Products Corporation Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Beijing Tiantan Biological Products Corporation Recent Developments/Updates
7.8.6 Beijing Tiantan Biological Products Corporation Competitive Strengths & Weaknesses
7.9 Hualan Biological
7.9.1 Hualan Biological Details
7.9.2 Hualan Biological Major Business
7.9.3 Hualan Biological Human Plasma Derivative Product and Services
7.9.4 Hualan Biological Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Hualan Biological Recent Developments/Updates
7.9.6 Hualan Biological Competitive Strengths & Weaknesses
7.10 Shanghai RAAS Blood Products
7.10.1 Shanghai RAAS Blood Products Details
7.10.2 Shanghai RAAS Blood Products Major Business
7.10.3 Shanghai RAAS Blood Products Human Plasma Derivative Product and Services
7.10.4 Shanghai RAAS Blood Products Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Shanghai RAAS Blood Products Recent Developments/Updates
7.10.6 Shanghai RAAS Blood Products Competitive Strengths & Weaknesses
7.11 Shandong Taibang Biological Products
7.11.1 Shandong Taibang Biological Products Details
7.11.2 Shandong Taibang Biological Products Major Business
7.11.3 Shandong Taibang Biological Products Human Plasma Derivative Product and Services
7.11.4 Shandong Taibang Biological Products Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Shandong Taibang Biological Products Recent Developments/Updates
7.11.6 Shandong Taibang Biological Products Competitive Strengths & Weaknesses
7.12 China Resources Boya Bio-pharmaceutical Group
7.12.1 China Resources Boya Bio-pharmaceutical Group Details
7.12.2 China Resources Boya Bio-pharmaceutical Group Major Business
7.12.3 China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Product and Services
7.12.4 China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 China Resources Boya Bio-pharmaceutical Group Recent Developments/Updates
7.12.6 China Resources Boya Bio-pharmaceutical Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Human Plasma Derivative and Key Manufacturers
8.2 Human Plasma Derivative Manufacturing Costs
8.3 Human Plasma Derivative Production Process
8.4 Human Plasma Derivative Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Human Plasma Derivative Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Human Plasma Derivative Typical Distributors
9.3 Human Plasma Derivative Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Human Plasma Derivative Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Human Plasma Derivative Production Value by Region (2017-2022) & (USD Million)
Table 3. World Human Plasma Derivative Production Value by Region (2023-2028) & (USD Million)
Table 4. World Human Plasma Derivative Production Value Market Share by Region (2017-2022)
Table 5. World Human Plasma Derivative Production Value Market Share by Region (2023-2028)
Table 6. World Human Plasma Derivative Production by Region (2017-2022) & (Tons)
Table 7. World Human Plasma Derivative Production by Region (2023-2028) & (Tons)
Table 8. World Human Plasma Derivative Production Market Share by Region (2017-2022)
Table 9. World Human Plasma Derivative Production Market Share by Region (2023-2028)
Table 10. World Human Plasma Derivative Average Price by Region (2017-2022) & (US$/Ton)
Table 11. World Human Plasma Derivative Average Price by Region (2023-2028) & (US$/Ton)
Table 12. Human Plasma Derivative Major Market Trends
Table 13. World Human Plasma Derivative Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Tons)
Table 14. World Human Plasma Derivative Consumption by Region (2017-2022) & (Tons)
Table 15. World Human Plasma Derivative Consumption Forecast by Region (2023-2028) & (Tons)
Table 16. World Human Plasma Derivative Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Human Plasma Derivative Producers in 2021
Table 18. World Human Plasma Derivative Production by Manufacturer (2017-2022) & (Tons)
Table 19. Production Market Share of Key Human Plasma Derivative Producers in 2021
Table 20. World Human Plasma Derivative Average Price by Manufacturer (2017-2022) & (US$/Ton)
Table 21. Global Human Plasma Derivative Company Evaluation Quadrant
Table 22. World Human Plasma Derivative Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Human Plasma Derivative Production Site of Key Manufacturer
Table 24. Human Plasma Derivative Market: Company Product Type Footprint
Table 25. Human Plasma Derivative Market: Company Product Application Footprint
Table 26. Human Plasma Derivative Competitive Factors
Table 27. Human Plasma Derivative New Entrant and Capacity Expansion Plans
Table 28. Human Plasma Derivative Mergers & Acquisitions Activity
Table 29. United States VS China Human Plasma Derivative Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Human Plasma Derivative Production Comparison, (2017 & 2021 & 2028) & (Tons)
Table 31. United States VS China Human Plasma Derivative Consumption Comparison, (2017 & 2021 & 2028) & (Tons)
Table 32. Major Manufacturer of Human Plasma Derivative in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Human Plasma Derivative Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022) & (Tons)
Table 36. United States Human Plasma Derivative Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Human Plasma Derivative in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Human Plasma Derivative Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022) & (Tons)
Table 41. China Human Plasma Derivative Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Human Plasma Derivative in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Human Plasma Derivative Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022) & (Tons)
Table 46. Rest of World Human Plasma Derivative Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Human Plasma Derivative Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Human Plasma Derivative Production by Type (2017-2022) & (Tons)
Table 49. World Human Plasma Derivative Production by Type (2023-2028) & (Tons)
Table 50. World Human Plasma Derivative Production Value by Type (2017-2022) & (USD Million)
Table 51. World Human Plasma Derivative Production Value by Type (2023-2028) & (USD Million)
Table 52. World Human Plasma Derivative Average Price by Type (2017-2022) & (US$/Ton)
Table 53. World Human Plasma Derivative Average Price by Type (2023-2028) & (US$/Ton)
Table 54. World Human Plasma Derivative Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Human Plasma Derivative Production by Application (2017-2022) & (Tons)
Table 56. World Human Plasma Derivative Production by Application (2023-2028) & (Tons)
Table 57. World Human Plasma Derivative Production Value by Application (2017-2022) & (USD Million)
Table 58. World Human Plasma Derivative Production Value by Application (2023-2028) & (USD Million)
Table 59. World Human Plasma Derivative Average Price by Application (2017-2022) & (US$/Ton)
Table 60. World Human Plasma Derivative Average Price by Application (2023-2028) & (US$/Ton)
Table 61. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 62. CSL Behring Major Business
Table 63. CSL Behring Human Plasma Derivative Product and Services
Table 64. CSL Behring Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. CSL Behring Recent Developments/Updates
Table 66. CSL Behring Competitive Strengths & Weaknesses
Table 67. Baxalta (Takeda) Basic Information, Manufacturing Base and Competitors
Table 68. Baxalta (Takeda) Major Business
Table 69. Baxalta (Takeda) Human Plasma Derivative Product and Services
Table 70. Baxalta (Takeda) Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Baxalta (Takeda) Recent Developments/Updates
Table 72. Baxalta (Takeda) Competitive Strengths & Weaknesses
Table 73. Grifols Basic Information, Manufacturing Base and Competitors
Table 74. Grifols Major Business
Table 75. Grifols Human Plasma Derivative Product and Services
Table 76. Grifols Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Grifols Recent Developments/Updates
Table 78. Grifols Competitive Strengths & Weaknesses
Table 79. Octapharma Basic Information, Manufacturing Base and Competitors
Table 80. Octapharma Major Business
Table 81. Octapharma Human Plasma Derivative Product and Services
Table 82. Octapharma Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Octapharma Recent Developments/Updates
Table 84. Octapharma Competitive Strengths & Weaknesses
Table 85. SK Plasma Basic Information, Manufacturing Base and Competitors
Table 86. SK Plasma Major Business
Table 87. SK Plasma Human Plasma Derivative Product and Services
Table 88. SK Plasma Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. SK Plasma Recent Developments/Updates
Table 90. SK Plasma Competitive Strengths & Weaknesses
Table 91. Fusion Health Care Basic Information, Manufacturing Base and Competitors
Table 92. Fusion Health Care Major Business
Table 93. Fusion Health Care Human Plasma Derivative Product and Services
Table 94. Fusion Health Care Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Fusion Health Care Recent Developments/Updates
Table 96. Fusion Health Care Competitive Strengths & Weaknesses
Table 97. Baxter International Basic Information, Manufacturing Base and Competitors
Table 98. Baxter International Major Business
Table 99. Baxter International Human Plasma Derivative Product and Services
Table 100. Baxter International Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Baxter International Recent Developments/Updates
Table 102. Baxter International Competitive Strengths & Weaknesses
Table 103. Beijing Tiantan Biological Products Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Beijing Tiantan Biological Products Corporation Major Business
Table 105. Beijing Tiantan Biological Products Corporation Human Plasma Derivative Product and Services
Table 106. Beijing Tiantan Biological Products Corporation Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Beijing Tiantan Biological Products Corporation Recent Developments/Updates
Table 108. Beijing Tiantan Biological Products Corporation Competitive Strengths & Weaknesses
Table 109. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 110. Hualan Biological Major Business
Table 111. Hualan Biological Human Plasma Derivative Product and Services
Table 112. Hualan Biological Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Hualan Biological Recent Developments/Updates
Table 114. Hualan Biological Competitive Strengths & Weaknesses
Table 115. Shanghai RAAS Blood Products Basic Information, Manufacturing Base and Competitors
Table 116. Shanghai RAAS Blood Products Major Business
Table 117. Shanghai RAAS Blood Products Human Plasma Derivative Product and Services
Table 118. Shanghai RAAS Blood Products Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Shanghai RAAS Blood Products Recent Developments/Updates
Table 120. Shanghai RAAS Blood Products Competitive Strengths & Weaknesses
Table 121. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 122. Shandong Taibang Biological Products Major Business
Table 123. Shandong Taibang Biological Products Human Plasma Derivative Product and Services
Table 124. Shandong Taibang Biological Products Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Shandong Taibang Biological Products Recent Developments/Updates
Table 126. China Resources Boya Bio-pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 127. China Resources Boya Bio-pharmaceutical Group Major Business
Table 128. China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Product and Services
Table 129. China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Human Plasma Derivative Raw Material
Table 131. Key Manufacturers of Human Plasma Derivative Raw Materials
Table 132. Human Plasma Derivative Typical Distributors
Table 133. Human Plasma Derivative Typical Customers
Table 1. World Human Plasma Derivative Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Human Plasma Derivative Production Value by Region (2017-2022) & (USD Million)
Table 3. World Human Plasma Derivative Production Value by Region (2023-2028) & (USD Million)
Table 4. World Human Plasma Derivative Production Value Market Share by Region (2017-2022)
Table 5. World Human Plasma Derivative Production Value Market Share by Region (2023-2028)
Table 6. World Human Plasma Derivative Production by Region (2017-2022) & (Tons)
Table 7. World Human Plasma Derivative Production by Region (2023-2028) & (Tons)
Table 8. World Human Plasma Derivative Production Market Share by Region (2017-2022)
Table 9. World Human Plasma Derivative Production Market Share by Region (2023-2028)
Table 10. World Human Plasma Derivative Average Price by Region (2017-2022) & (US$/Ton)
Table 11. World Human Plasma Derivative Average Price by Region (2023-2028) & (US$/Ton)
Table 12. Human Plasma Derivative Major Market Trends
Table 13. World Human Plasma Derivative Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Tons)
Table 14. World Human Plasma Derivative Consumption by Region (2017-2022) & (Tons)
Table 15. World Human Plasma Derivative Consumption Forecast by Region (2023-2028) & (Tons)
Table 16. World Human Plasma Derivative Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Human Plasma Derivative Producers in 2021
Table 18. World Human Plasma Derivative Production by Manufacturer (2017-2022) & (Tons)
Table 19. Production Market Share of Key Human Plasma Derivative Producers in 2021
Table 20. World Human Plasma Derivative Average Price by Manufacturer (2017-2022) & (US$/Ton)
Table 21. Global Human Plasma Derivative Company Evaluation Quadrant
Table 22. World Human Plasma Derivative Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Human Plasma Derivative Production Site of Key Manufacturer
Table 24. Human Plasma Derivative Market: Company Product Type Footprint
Table 25. Human Plasma Derivative Market: Company Product Application Footprint
Table 26. Human Plasma Derivative Competitive Factors
Table 27. Human Plasma Derivative New Entrant and Capacity Expansion Plans
Table 28. Human Plasma Derivative Mergers & Acquisitions Activity
Table 29. United States VS China Human Plasma Derivative Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Human Plasma Derivative Production Comparison, (2017 & 2021 & 2028) & (Tons)
Table 31. United States VS China Human Plasma Derivative Consumption Comparison, (2017 & 2021 & 2028) & (Tons)
Table 32. Major Manufacturer of Human Plasma Derivative in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Human Plasma Derivative Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022) & (Tons)
Table 36. United States Human Plasma Derivative Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Human Plasma Derivative in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Human Plasma Derivative Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022) & (Tons)
Table 41. China Human Plasma Derivative Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Human Plasma Derivative in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Human Plasma Derivative Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Human Plasma Derivative Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Human Plasma Derivative Production by Domestic Manufacturer, (2017-2022) & (Tons)
Table 46. Rest of World Human Plasma Derivative Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Human Plasma Derivative Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Human Plasma Derivative Production by Type (2017-2022) & (Tons)
Table 49. World Human Plasma Derivative Production by Type (2023-2028) & (Tons)
Table 50. World Human Plasma Derivative Production Value by Type (2017-2022) & (USD Million)
Table 51. World Human Plasma Derivative Production Value by Type (2023-2028) & (USD Million)
Table 52. World Human Plasma Derivative Average Price by Type (2017-2022) & (US$/Ton)
Table 53. World Human Plasma Derivative Average Price by Type (2023-2028) & (US$/Ton)
Table 54. World Human Plasma Derivative Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Human Plasma Derivative Production by Application (2017-2022) & (Tons)
Table 56. World Human Plasma Derivative Production by Application (2023-2028) & (Tons)
Table 57. World Human Plasma Derivative Production Value by Application (2017-2022) & (USD Million)
Table 58. World Human Plasma Derivative Production Value by Application (2023-2028) & (USD Million)
Table 59. World Human Plasma Derivative Average Price by Application (2017-2022) & (US$/Ton)
Table 60. World Human Plasma Derivative Average Price by Application (2023-2028) & (US$/Ton)
Table 61. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 62. CSL Behring Major Business
Table 63. CSL Behring Human Plasma Derivative Product and Services
Table 64. CSL Behring Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. CSL Behring Recent Developments/Updates
Table 66. CSL Behring Competitive Strengths & Weaknesses
Table 67. Baxalta (Takeda) Basic Information, Manufacturing Base and Competitors
Table 68. Baxalta (Takeda) Major Business
Table 69. Baxalta (Takeda) Human Plasma Derivative Product and Services
Table 70. Baxalta (Takeda) Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Baxalta (Takeda) Recent Developments/Updates
Table 72. Baxalta (Takeda) Competitive Strengths & Weaknesses
Table 73. Grifols Basic Information, Manufacturing Base and Competitors
Table 74. Grifols Major Business
Table 75. Grifols Human Plasma Derivative Product and Services
Table 76. Grifols Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Grifols Recent Developments/Updates
Table 78. Grifols Competitive Strengths & Weaknesses
Table 79. Octapharma Basic Information, Manufacturing Base and Competitors
Table 80. Octapharma Major Business
Table 81. Octapharma Human Plasma Derivative Product and Services
Table 82. Octapharma Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Octapharma Recent Developments/Updates
Table 84. Octapharma Competitive Strengths & Weaknesses
Table 85. SK Plasma Basic Information, Manufacturing Base and Competitors
Table 86. SK Plasma Major Business
Table 87. SK Plasma Human Plasma Derivative Product and Services
Table 88. SK Plasma Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. SK Plasma Recent Developments/Updates
Table 90. SK Plasma Competitive Strengths & Weaknesses
Table 91. Fusion Health Care Basic Information, Manufacturing Base and Competitors
Table 92. Fusion Health Care Major Business
Table 93. Fusion Health Care Human Plasma Derivative Product and Services
Table 94. Fusion Health Care Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Fusion Health Care Recent Developments/Updates
Table 96. Fusion Health Care Competitive Strengths & Weaknesses
Table 97. Baxter International Basic Information, Manufacturing Base and Competitors
Table 98. Baxter International Major Business
Table 99. Baxter International Human Plasma Derivative Product and Services
Table 100. Baxter International Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Baxter International Recent Developments/Updates
Table 102. Baxter International Competitive Strengths & Weaknesses
Table 103. Beijing Tiantan Biological Products Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Beijing Tiantan Biological Products Corporation Major Business
Table 105. Beijing Tiantan Biological Products Corporation Human Plasma Derivative Product and Services
Table 106. Beijing Tiantan Biological Products Corporation Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Beijing Tiantan Biological Products Corporation Recent Developments/Updates
Table 108. Beijing Tiantan Biological Products Corporation Competitive Strengths & Weaknesses
Table 109. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 110. Hualan Biological Major Business
Table 111. Hualan Biological Human Plasma Derivative Product and Services
Table 112. Hualan Biological Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Hualan Biological Recent Developments/Updates
Table 114. Hualan Biological Competitive Strengths & Weaknesses
Table 115. Shanghai RAAS Blood Products Basic Information, Manufacturing Base and Competitors
Table 116. Shanghai RAAS Blood Products Major Business
Table 117. Shanghai RAAS Blood Products Human Plasma Derivative Product and Services
Table 118. Shanghai RAAS Blood Products Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Shanghai RAAS Blood Products Recent Developments/Updates
Table 120. Shanghai RAAS Blood Products Competitive Strengths & Weaknesses
Table 121. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 122. Shandong Taibang Biological Products Major Business
Table 123. Shandong Taibang Biological Products Human Plasma Derivative Product and Services
Table 124. Shandong Taibang Biological Products Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Shandong Taibang Biological Products Recent Developments/Updates
Table 126. China Resources Boya Bio-pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 127. China Resources Boya Bio-pharmaceutical Group Major Business
Table 128. China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Product and Services
Table 129. China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Human Plasma Derivative Raw Material
Table 131. Key Manufacturers of Human Plasma Derivative Raw Materials
Table 132. Human Plasma Derivative Typical Distributors
Table 133. Human Plasma Derivative Typical Customers
LIST OF FIGURES
Figure 1. Human Plasma Derivative Picture
Figure 2. World Human Plasma Derivative Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Human Plasma Derivative Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 5. World Human Plasma Derivative Average Price (2017-2028) & (US$/Ton)
Figure 6. World Human Plasma Derivative Production Value Market Share by Region (2017-2028)
Figure 7. World Human Plasma Derivative Production Market Share by Region (2017-2028)
Figure 8. North America Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 9. Europe Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 10. China Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 11. Japan Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 12. Human Plasma Derivative Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Plasma Derivative Demand (2017-2028) & (Tons)
Figure 15. World Human Plasma Derivative Consumption Market Share by Region (2017-2028)
Figure 16. United States Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 17. China Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 18. Europe Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 19. Japan Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 20. South Korea Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 21. ASEAN Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 22. India Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 23. Producer Shipments of Human Plasma Derivative by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Plasma Derivative Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Plasma Derivative Markets in 2021
Figure 26. United States VS China: Human Plasma Derivative Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Human Plasma Derivative Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Human Plasma Derivative Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Human Plasma Derivative in United States
Figure 30. Key Producers and Market Share of Human Plasma Derivative in China
Figure 31. Key Producers and Market Share of Human Plasma Derivative in Rest of World
Figure 32. World Human Plasma Derivative Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Human Plasma Derivative Production Value Market Share by Type in 2021
Figure 34. Albumin
Figure 35. Blood coagulation Factors
Figure 36. Immuno Globulins
Figure 37. Haptoglobin
Figure 38. C1-Inactivator
Figure 39. World Human Plasma Derivative Production Market Share by Type (2017-2028)
Figure 40. World Human Plasma Derivative Production Value Market Share by Type (2017-2028)
Figure 41. World Human Plasma Derivative Average Price by Type (2017-2028) & (US$/Ton)
Figure 42. World Human Plasma Derivative Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Human Plasma Derivative Production Value Market Share by Application in 2021
Figure 44. Hospitals
Figure 45. Clinics
Figure 46. Biology Laboratory
Figure 47. Others
Figure 48. World Human Plasma Derivative Production Market Share by Application (2017-2028)
Figure 49. World Human Plasma Derivative Production Value Market Share by Application (2017-2028)
Figure 50. World Human Plasma Derivative Average Price by Application (2017-2028) & (US$/Ton)
Figure 51. Manufacturing Cost Structure Analysis of Human Plasma Derivative in 2021
Figure 52. Manufacturing Process Analysis of Human Plasma Derivative
Figure 53. Human Plasma Derivative Industrial Chain
Figure 54. Distribution Channel Breakdown for Human Plasma Derivative Shipments (%): 2017-2028
Figure 55. Direct Channel Pros & Cons
Figure 56. Indirect Channel Pros & Cons
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Human Plasma Derivative Picture
Figure 2. World Human Plasma Derivative Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Human Plasma Derivative Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 5. World Human Plasma Derivative Average Price (2017-2028) & (US$/Ton)
Figure 6. World Human Plasma Derivative Production Value Market Share by Region (2017-2028)
Figure 7. World Human Plasma Derivative Production Market Share by Region (2017-2028)
Figure 8. North America Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 9. Europe Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 10. China Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 11. Japan Human Plasma Derivative Production (2017-2028) & (Tons)
Figure 12. Human Plasma Derivative Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Plasma Derivative Demand (2017-2028) & (Tons)
Figure 15. World Human Plasma Derivative Consumption Market Share by Region (2017-2028)
Figure 16. United States Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 17. China Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 18. Europe Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 19. Japan Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 20. South Korea Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 21. ASEAN Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 22. India Human Plasma Derivative Consumption (2017-2028) & (Tons)
Figure 23. Producer Shipments of Human Plasma Derivative by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Plasma Derivative Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Plasma Derivative Markets in 2021
Figure 26. United States VS China: Human Plasma Derivative Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Human Plasma Derivative Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Human Plasma Derivative Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Human Plasma Derivative in United States
Figure 30. Key Producers and Market Share of Human Plasma Derivative in China
Figure 31. Key Producers and Market Share of Human Plasma Derivative in Rest of World
Figure 32. World Human Plasma Derivative Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Human Plasma Derivative Production Value Market Share by Type in 2021
Figure 34. Albumin
Figure 35. Blood coagulation Factors
Figure 36. Immuno Globulins
Figure 37. Haptoglobin
Figure 38. C1-Inactivator
Figure 39. World Human Plasma Derivative Production Market Share by Type (2017-2028)
Figure 40. World Human Plasma Derivative Production Value Market Share by Type (2017-2028)
Figure 41. World Human Plasma Derivative Average Price by Type (2017-2028) & (US$/Ton)
Figure 42. World Human Plasma Derivative Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Human Plasma Derivative Production Value Market Share by Application in 2021
Figure 44. Hospitals
Figure 45. Clinics
Figure 46. Biology Laboratory
Figure 47. Others
Figure 48. World Human Plasma Derivative Production Market Share by Application (2017-2028)
Figure 49. World Human Plasma Derivative Production Value Market Share by Application (2017-2028)
Figure 50. World Human Plasma Derivative Average Price by Application (2017-2028) & (US$/Ton)
Figure 51. Manufacturing Cost Structure Analysis of Human Plasma Derivative in 2021
Figure 52. Manufacturing Process Analysis of Human Plasma Derivative
Figure 53. Human Plasma Derivative Industrial Chain
Figure 54. Distribution Channel Breakdown for Human Plasma Derivative Shipments (%): 2017-2028
Figure 55. Direct Channel Pros & Cons
Figure 56. Indirect Channel Pros & Cons
Figure 57. Methodology
Figure 58. Research Process and Data Source
